A Comprehensive Update of ICET-A Network on COVID-19 in Thalassemias: What We Know and Where We Stand

A review of the literature on COVID-19 pandemic in patients with thalassemias is presented. Globally, the prevalence of COVID-19 among β-thalassemia patients seems to be lower than in general population; associated co-morbidities aggravated the severity of COVID- 19, leading to a poorer prognosis, i...

Descripción completa

Detalles Bibliográficos
Autores principales: de Sanctis, Vincenzo, Canatan, Duran, Corrons, Joan Lluis Vives, Karimi, Mehran, Daar, Shahina, Kattamis, Christos, Soliman, Ashraf T, Wali, Yasser, Alkindi, Salam, Huseynov, Valeh, Nasibova, Afag, Tiryaki, Tarık Onur, Sezgin Evim, Melike, Gunes, Adalet Meral, Karakas, Zeynep, Christou, Soteroula, Yassin, Mohamed A, Galati, Maria Concetta, Campisi, Saveria, Zarei, Tahereh, Khater, Doaa, Oymak, Yesim, Kaleva, Valeriya, Stoyanova, Denka, Banchev, Atanas, Skafida, Myrto, Kilinc, Yurdanur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2020
Materias:
Reviews / Focus on
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716954/
https://www.ncbi.nlm.nih.gov/pubmed/32921722
http://dx.doi.org/10.23750/abm.v91i3.10063
Descripción
Sumario:A review of the literature on COVID-19 pandemic in patients with thalassemias is presented. Globally, the prevalence of COVID-19 among β-thalassemia patients seems to be lower than in general population; associated co-morbidities aggravated the severity of COVID- 19, leading to a poorer prognosis, irrespective of age. A multicenter registry will enhance the understanding of COVID-19 in these patients and will lead to more evidence-based management recommendations. (www.actabiomedica.it)

Ejemplares similares